Your browser doesn't support javascript.
loading
Putative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals.
Johansson, Hanna K L; Damdimopoulou, Pauliina; van Duursen, Majorie B M; Boberg, Julie; Franssen, Delphine; de Cock, Marijke; Jääger, Kersti; Wagner, Magdalena; Velthut-Meikas, Agne; Xie, Yuling; Connolly, Lisa; Lelandais, Pauline; Mazaud-Guittot, Severine; Salumets, Andres; Draskau, Monica Kam; Filis, Panagiotis; Fowler, Paul A; Christiansen, Sofie; Parent, Anne-Simone; Svingen, Terje.
Afiliação
  • Johansson HKL; Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, 2800, Kongens Lyngby, Denmark.
  • Damdimopoulou P; Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, 14186, Stockholm, Sweden.
  • van Duursen MBM; Department Environment and Health, Vrije Universiteit Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands.
  • Boberg J; Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, 2800, Kongens Lyngby, Denmark.
  • Franssen D; Neuroendocrinology Unit, GIGA Neurosciences, University of Liège, Sart-Tilman, 4000, Liège, Belgium.
  • de Cock M; Faculty of Science, Vrije Universiteit Amsterdam, 1081 HV, Amsterdam, The Netherlands.
  • Jääger K; Competence Centre on Health Technologies, Tartu, Estonia.
  • Wagner M; Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, 14186, Stockholm, Sweden.
  • Velthut-Meikas A; Competence Centre on Health Technologies, Tartu, Estonia.
  • Xie Y; Department of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, Tallinn, Estonia.
  • Connolly L; Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5DL, Northern Ireland, UK.
  • Lelandais P; Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5DL, Northern Ireland, UK.
  • Mazaud-Guittot S; Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) UMR_S 1085, University Rennes, 35000, Rennes, France.
  • Salumets A; Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) UMR_S 1085, University Rennes, 35000, Rennes, France.
  • Draskau MK; Competence Centre on Health Technologies, Tartu, Estonia.
  • Filis P; Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
  • Fowler PA; Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
  • Christiansen S; Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, 2800, Kongens Lyngby, Denmark.
  • Parent AS; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK.
  • Svingen T; Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK.
Arch Toxicol ; 94(10): 3359-3379, 2020 10.
Article em En | MEDLINE | ID: mdl-32638039
ABSTRACT
Modern living challenges female reproductive health. We are witnessing a rise in reproductive disorders and drop in birth rates across the world. The reasons for these manifestations are multifaceted and most likely include continuous exposure to an ever-increasing number of chemicals. The cause-effect relationships between chemical exposure and female reproductive disorders, however, have proven problematic to determine. This has made it difficult to assess the risks chemical exposures pose to a woman's reproductive development and function. To address this challenge, this review uses the adverse outcome pathway (AOP) concept to summarize current knowledge about how chemical exposure can affect female reproductive health. We have a special focus on effects on the ovaries, since they are essential for lifelong reproductive health in women, being the source of both oocytes and several reproductive hormones, including sex steroids. The AOP framework is widely accepted as a new tool for toxicological safety assessment that enables better use of mechanistic knowledge for regulatory purposes. AOPs equip assessors and regulators with a pragmatic network of linear cause-effect relationships, enabling the use of a wider range of test method data in chemical risk assessment and regulation. Based on current knowledge, we propose ten putative AOPs relevant for female reproductive disorders that can be further elaborated and potentially be included in the AOPwiki. This effort is an important step towards better safeguarding the reproductive health of all girls and women.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ovário / Exposição Materna / Saúde Reprodutiva / Segurança Química / Rotas de Resultados Adversos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ovário / Exposição Materna / Saúde Reprodutiva / Segurança Química / Rotas de Resultados Adversos Idioma: En Ano de publicação: 2020 Tipo de documento: Article